Latest News about JNJ
Recent news which mentions JNJ
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
From Benzinga
Revenge of the Boring Stocks! Dividends Are Sexy Again.
January 03, 2024
From InvestorPlace
This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns
January 03, 2024
From Benzinga
From Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year
January 03, 2024
From Motley Fool
From Benzinga
Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024
January 02, 2024
From Benzinga
From Benzinga
2024’s Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns
January 01, 2024
From InvestorPlace
Meet the 2024 Dogs of the Dow
January 01, 2024
From Motley Fool
From Motley Fool
Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires
December 31, 2023
From InvestorPlace
2 Best Warren Buffett Stocks to Buy for the Long Haul
December 30, 2023
From Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
December 29, 2023
Tickers
JNJ
From Benzinga
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
December 29, 2023
From Motley Fool
Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times
December 29, 2023
From InvestorPlace
Contagious Opportunities: Norovirus Cases Are On The Rise, These Are The Stocks That May Be Impacted
December 28, 2023
From Benzinga
Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024
December 28, 2023
From InvestorPlace
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
December 28, 2023
From Benzinga
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
December 28, 2023
From Benzinga
From Motley Fool
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
December 27, 2023
From InvestorPlace
Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?
December 27, 2023
From Motley Fool
3 No-Brainer Stocks to Buy With $200 Right Now
December 27, 2023
From Motley Fool
Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023
December 26, 2023
From Benzinga
7 Rock-Solid Dividend Stocks to Trust in Difficult Times
December 25, 2023
From InvestorPlace
2 Top Dividend Stocks You Can Buy and Hold Forever
December 24, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.